Scilex Holding Co

Ownership Transactions Reported by 18 Insiders

Symbol
SCLX, SCLXW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
960 San Antonio Road, Palo Alto, California

Insiders trading volume in the past year

Scilex Holding Co executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
SCLX Stock Acquisition JV LLC 10%+ Owner $52.9M Sep 22, 2023
Sorrento Therapeutics, Inc. 10%+ Owner $1.69M Sep 21, 2023
Henry Ji Executive Chairperson, Director $863K +$44K +5.37% Jun 18, 2024
Jaisim Shah Chief Executive Officer and President, Director $352K +$122K +53.1% Jun 20, 2024
Jay Chun Director $152K +$51.6K +51.7% Jun 20, 2024
Stephen Hoi Ma Chief Financial Officer $22.8K +$12.4K +121% Jun 20, 2024
Yue Alexander Wu Director $7.05K Jun 20, 2024
Dorman Followwill Director $1.78K Jun 26, 2024
Annu Navani Director Aug 16, 2024
Laura Hamill Director Jan 17, 2023
Tommy G. Thompson Director Jan 17, 2023
David Lemus Director Mar 15, 2024
Elizabeth Czerepak Executive Vice President, Chief Business Officer and Chief Financial Officer Jan 17, 2023
Tien-Li Lee Director Jan 17, 2023
Steve Myint Director, Effective November 10, 2022, Steve Myint is no longer a Director of Vickers Vantage Corp. I Nov 10, 2022
Suneel G. Kaji Director, Effective November 10, 2022, Suneel G. Kaji is no longer a Director of Vickers Vantage Corp. I Nov 10, 2022
Pei Wei Woo Director, Effective November 10, 2022, Pei Wei Woo is no longer a Director of Vickers Vantage Corp. I Nov 10, 2022
Vickers Venture Fund VI Pte Ltd Other*, 10%+ Owner Nov 10, 2022

Recent Insider Transactions by Companies or Individuals for Scilex Holding Co

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.